Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-02-07 Sale |
2023-02-09 4:30 pm |
Magenta Therapeutics Inc. | MGTA | Third Rock Ventures IV L.P. Third Rock Ventures GP IV L.P. TRV GP IV LLC 10% Owner |
3,700,000 | $0.82595 | $3,056,000 | 3,058,204 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-09-11 Option Award |
2023-09-13 9:14 pm |
N/A 2033-09-10 |
Dianthus Therapeutics Inc. | DNTH | McGeorge Anne Director |
6,500 | $0 | 6,500 (Direct) |
View |
| 2023-09-11 Option Award |
2023-09-13 9:13 pm |
N/A 2033-09-10 |
Dianthus Therapeutics Inc. | DNTH | MOULDER LEON O JR Director |
6,500 | $0 | 6,500 (Direct) |
View |
Ownership |
2023-09-13 8:55 pm |
N/A N/A |
Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner |
0 | $0 | 1,819,579 (Indirect) |
View |
Ownership |
2023-09-13 8:52 pm |
N/A 2032-06-06 |
Dianthus Therapeutics Inc. | DNTH | Soteropoulos Paula Director |
0 | $0 | 28,792 (Direct) |
View |
Ownership |
2023-09-13 8:51 pm |
N/A 2031-11-03 |
Dianthus Therapeutics Inc. | DNTH | Garcia Marino CEO and President |
0 | $0 | 508,663 (Direct) |
View |
Ownership |
2023-09-13 8:50 pm |
N/A 2032-06-06 |
Dianthus Therapeutics Inc. | DNTH | Randhawa Simrat Chief Medical Officer |
0 | $0 | 95,974 (Direct) |
View |
Ownership |
2023-09-13 8:48 pm |
N/A 2033-06-28 |
Dianthus Therapeutics Inc. | DNTH | Veness Adam M See Remarks |
0 | $0 | 88,240 (Direct) |
View |
Ownership |
2023-09-13 8:47 pm |
N/A 2032-06-06 |
Dianthus Therapeutics Inc. | DNTH | CARR EDWARD CHIEF ACCOUNTING OFFICER |
0 | $0 | 95,974 (Direct) |
View |
Ownership |
2023-09-13 8:46 pm |
N/A N/A |
Dianthus Therapeutics Inc. | DNTH | MOULDER LEON O JR Director |
0 | $0 | 1,270,078 (Indirect) |
View |
Ownership |
2023-09-13 8:45 pm |
N/A 2032-06-06 |
Dianthus Therapeutics Inc. | DNTH | Savitz Ryan CHIEF FINANCIAL OFFICER |
0 | $0 | 124,766 (Direct) |
View |
| 2022-11-30 Option Award |
2022-12-02 4:26 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Beetham Thomas W. See Remarks |
3,000 | $0.94 | 19,897 (Direct) |
View |
| 2022-11-30 Option Award |
2022-12-02 4:23 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Mahoney Stephen F. See Remarks |
3,000 | $0.94 | 17,264 (Direct) |
View |
| 2022-11-30 Option Award |
2022-12-02 4:23 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Deardorf Caren Chief Commercial Officer |
3,000 | $0.94 | 19,762 (Direct) |
View |
| 2022-11-30 Option Award |
2022-12-02 4:23 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | GARDNER JASON See Remarks |
3,000 | $0.94 | 944,954 (Direct) |
View |
| 2022-11-30 Option Award |
2022-12-02 4:19 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Stants Kristen Chief People Officer |
3,000 | $0.94 | 20,264 (Direct) |
View |
| 2022-08-15 Option Award |
2022-08-17 08:19 am |
N/A 2032-08-14 |
Magenta Therapeutics Inc. | MGTA | VASCONCELLES MICHAEL Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-08-01 Option Award |
2022-08-01 9:18 pm |
N/A 2032-07-31 |
Magenta Therapeutics Inc. | MGTA | Olson Lisa See Remarks |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-08-01 Option Award |
2022-08-01 9:14 pm |
N/A 2032-07-31 |
Magenta Therapeutics Inc. | MGTA | Beetham Thomas W. See Remarks |
75,000 | $0 | 75,000 (Direct) |
View |
| 2022-08-01 Option Award |
2022-08-01 9:14 pm |
N/A 2032-07-31 |
Magenta Therapeutics Inc. | MGTA | Humphrey Jeffrey Chief Medical Officer |
75,000 | $0 | 75,000 (Direct) |
View |
| 2022-08-01 Option Award |
2022-08-01 9:13 pm |
N/A 2032-07-31 |
Magenta Therapeutics Inc. | MGTA | GARDNER JASON See Remarks |
187,500 | $0 | 187,500 (Direct) |
View |
| 2022-08-01 Option Award |
2022-08-01 9:13 pm |
N/A 2032-07-31 |
Magenta Therapeutics Inc. | MGTA | Nichols David Wayne Chief Technical Officer |
75,000 | $0 | 75,000 (Direct) |
View |
| 2022-08-01 Option Award |
2022-08-01 9:11 pm |
N/A 2032-07-31 |
Magenta Therapeutics Inc. | MGTA | Mahoney Stephen F. See Remarks |
130,000 | $0 | 130,000 (Direct) |
View |
| 2022-08-01 Option Award |
2022-08-01 9:11 pm |
N/A 2032-07-31 |
Magenta Therapeutics Inc. | MGTA | Stants Kristen Chief People Officer |
85,000 | $0 | 85,000 (Direct) |
View |
| 2022-08-01 Option Award |
2022-08-01 9:10 pm |
N/A 2032-07-31 |
Magenta Therapeutics Inc. | MGTA | Deardorf Caren Chief Commercial Officer |
75,000 | $0 | 75,000 (Direct) |
View |
| 2022-06-28 Option Award |
2022-06-30 7:28 pm |
N/A 2032-06-27 |
Magenta Therapeutics Inc. | MGTA | Booth Bruce Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-28 Option Award |
2022-06-30 6:37 pm |
N/A 2032-06-27 |
Magenta Therapeutics Inc. | MGTA | Daniel Thomas O Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-28 Option Award |
2022-06-30 6:36 pm |
N/A 2032-06-27 |
Magenta Therapeutics Inc. | MGTA | Lawton Alison Frances Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-28 Option Award |
2022-06-30 6:34 pm |
N/A 2032-06-27 |
Magenta Therapeutics Inc. | MGTA | RONNEBERG AMY L Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-28 Option Award |
2022-06-30 6:34 pm |
N/A 2032-06-27 |
Magenta Therapeutics Inc. | MGTA | Albers Jeffrey W. Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-28 Option Award |
2022-06-30 6:33 pm |
N/A 2032-06-27 |
Magenta Therapeutics Inc. | MGTA | Scadden David Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-28 Option Award |
2022-06-30 6:33 pm |
N/A 2032-06-27 |
Magenta Therapeutics Inc. | MGTA | McGeorge Anne Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-05-31 Option Award |
2022-06-06 4:06 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Stants Kristen Chief People Officer |
3,000 | $0.99 | 17,264 (Direct) |
View |
| 2022-05-31 Option Award |
2022-06-06 4:05 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Deardorf Caren Chief Commercial Officer |
3,000 | $0.99 | 16,762 (Direct) |
View |
| 2022-05-31 Option Award |
2022-06-06 4:05 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | GARDNER JASON See Remarks |
3,000 | $0.99 | 941,954 (Direct) |
View |
| 2022-05-31 Option Award |
2022-06-06 4:05 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Beetham Thomas W. See Remarks |
3,000 | $0.99 | 16,897 (Direct) |
View |
| 2022-05-17 Option Award |
2022-05-19 4:24 pm |
N/A 2032-05-16 |
Magenta Therapeutics Inc. | MGTA | Olson Lisa See Remarks |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-05-17 Option Award |
2022-05-19 4:23 pm |
N/A 2032-05-16 |
Magenta Therapeutics Inc. | MGTA | Humphrey Jeffrey Chief Medical Officer |
50,000 | $0 | 50,000 (Direct) |
View |